5 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
The Human Brain Project (HBP)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2016,
Understanding the human brain is one of the greatest challenges facing 21st century science. If we can rise to the challenge, we can gain profound insights into what makes us human, develop new treatments for brain diseases and build revolutionary new computing technologies. Today, for the first time, modern ICT has brought these goals within sight. The goal of the Human Brain Project, part of the ...
Voir le projet
116
Participants partenaires
TERMINÉ
Genetic and Epigenetic Networks in Cognitive Dysfunction (GENCODYS)
Date du début: 1 mai 2010, Date de fin: 30 avr. 2015,
Mutations in about 400 different genes have been associated with Cognitive Disorders (CD), such as mental retardation, autism, neurodegenerative disorders, and psychiatric disorders. Whereas CD impose a major medical and socio-economical problem, there are no systematic studies that aim to provide insight into common mechanisms in CD. We propose a systems biology approach to gain insight into comm ...
Voir le projet
15
Participants partenaires
TERMINÉ
Synaptic Systems: dissecting brain function in health and disease (SYNSYS)
Date du début: 1 juil. 2010, Date de fin: 31 déc. 2014,
Major disorders of the Central Nervous System (CNS) affect one in three people in the developed world, often seriously disable the affected individual, and together account for the single largest burden on the healthcare systems of the EU. Most of these disorders act at the neuronal synapse, a cellular organelle comprising in the order of 2000 proteins. Pleiotropy, cross-talk between proteins and ...
Voir le projet
19
Participants partenaires
TERMINÉ
European Consortium on Synaptic Protein Networks in Neurological and Psychiatric Diseases (EUROSPIN)
Date du début: 1 janv. 2010, Date de fin: 30 juin 2014,
"Signalling at nerve cell synapses - a key determinant of all aspects of brain function - depends on the function of hundreds of synaptic proteins and their interactions. Numerous recent studies showed that a wide range of neurological and psychiatric diseases are 'synaptopathies' whose onset and progression are due to mutations of synaptic proteins and subsequent synaptic dysfunctions. EUROSPIN w ...
Voir le projet
19
Participants partenaires
TERMINÉ
The PharMEA Platform: Multi-Electrode Array technology based platform for industrial pharmacology and toxicology drug screening (PharMEA)
Date du début: 1 sept. 2009, Date de fin: 30 nov. 2011,
The project PharMEA is based on the technology platform of multi-electrode arrays, which have been widely used for electrophysiological experiments on neuronal and cardiac tissues. Some of the key advantages of MEA technology include ease of use, non-invasive measurements and simultaneous multi-site recording & stimulation capability. Despite these key advantages, MEA technology utilization has re ...
Voir le projet